Cover art for BIO-key International Q3 2026 Earnings Miss

BIO-key International Q3 2026 Earnings Miss

BIO-key International's Q3 2026 earnings miss hides operational progress as stock rises.

7 cards · 1m 10s · tap to begin

From · · · 1m 10s

BIO-key International Q3 2026 Earnings Miss

BIO-key International's Q3 2026 earnings miss hides operational progress as stock rises.

In brief

BIO-key International's Q3 2026 earnings miss hides operational progress as stock rises. BIO-key International reported a $4.01 per share loss in Q3 2026, missing analyst estimates, but stock rose 4.0% to $2.58 as investors saw margin improvements from software licensing. Originally reported by Alphastreet - Earnings…

Q3 2026 Earnings Results

BIO-key International reported an EPS loss of $4.01 per share in Q3 2026, missing analyst estimates of a $0.35 loss.

Revenue and Stock Performance

Revenue fell to $1.5M from $2.4M estimates, but stock rose 4.0% to $2.58.

Margin Expansion Story

BKYI

Gross margin expanded to 89.3% from 77% a year ago, driven by software license revenue growth.

“license fee revenue grew 39% year over year, and that high-margin recurring revenue lifted our gross margin to 90%, from 77% a year ago and helped reduce our operating loss by 8%”

Revenue Composition Shift

Software license fee revenue grew 39.0%, offsetting lower hardware sales despite a 4.3% year-over-year revenue decline.

Sequential Deterioration

Revenue declined from $2.1M in Q1 2026 to $1.5M in Q3 2026, with EPS collapsing from $0.15 to $4.01 loss.

Q1 2027 Inflection Point

Q1 2027 Inflection Point

Management targets profitability by Q1 2027 with $1.2 million in annual license fee renewals.

“We expect roughly $1.2 million in annual license fee renewals in the first quarter alone, and we are targeting profitability as we approach that timeframe”

Market Reaction

Stock rose 4.0% despite earnings miss, signaling investor confidence in margin improvements and Q1 2027 renewal cycle.

The headline

BIO-key International reported a $4.01 per share loss in Q3 2026, missing analyst estimates, but stock rose 4.0% to $2.58 as investors saw margin improvements from software licensing.

Read the original on Alphastreet - Earnings Decoded. Market Intelligence Delivered

Read the TL;DR — this story on one card.

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on bio-key international and related topics.